S. 3103: To authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to products of certain countries.
This bill seeks to authorize the continuation of nondiscriminatory treatment, also known as normal trade relations, for products coming from certain countries. Here are the key points:
1. Presidential Authority
The bill gives the President the power to terminate the application of a specific section of the Trade Act of 1974 for certain countries. This means the President can decide that a specified country will no longer be subject to the restrictions in this Trade Act.
2. Extension of Nondiscriminatory Treatment
Following the determination that a country is no longer restricted under the Trade Act, the President can proclaim that the products from that country will receive nondiscriminatory treatment. This allows these products to be imported and sold in the United States without additional tariffs or trade barriers that might have previously been in place.
3. Termination of Previous Restrictions
Once a country is granted nondiscriminatory treatment under this bill, the previous restrictions set forth by the Trade Act of 1974 will no longer apply to that country.
4. Definition of Covered Countries
The bill defines "covered countries" as any nation except for Belarus, Cuba, and North Korea. This means that the bill is intended to provide trade benefits to a range of countries, excluding those that are considered to have significant trade restrictions or diplomatic issues with the United States.
5. Impact Overview
In summary, this legislation would enable the President to extend normal trade relations to specific countries and remove trade restrictions that were previously enforced under the Trade Act of 1974, thereby allowing easier access for foreign products to the U.S. market.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
4 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Nov. 04, 2025 | Introduced in Senate |
| Nov. 04, 2025 | Read twice and referred to the Committee on Finance. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.